Tower Research Capital LLC (Trc) Abbott Laboratories Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Abbott Laboratories stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 33,699 shares of ABT stock, worth $3.91 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
33,699
Previous 118,178
71.48%
Holding current value
$3.91 Million
Previous $12.3 Million
68.71%
% of portfolio
0.1%
Previous 0.21%
Shares
29 transactions
Others Institutions Holding ABT
# of Institutions
3,184Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.5 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.89 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.62 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.18 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $203B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...